Clinical trial
Core A: The Hepato/Renal Fibrocystic Diseases Translational Resource (ARPKD Database Study)
NCT01401998 is registered in ClinicalTrials.gov with Children's Hospital of Philadelphia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Core A: The Hepato/Renal Fibrocystic Diseases Translational Resource (ARPKD Database Study)
- Lead sponsor
- Children's Hospital of Philadelphia
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- June 30, 2011
- Completion date
- December 31, 2030
- Enrollment
- 200 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
autosomal recessive polycystic kidney disease, bardet biedl syndrome, caroli syndrome, congenital hepatic fibrosis, glomerulocystic kidney disease, hepato/renal fibrocystic disease, joubert syndrome, meckel-gruber syndrome, nephronophthisis, oro-facial-digital syndrome type i